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Abstract
It has been suggested that mitochondrial dysfunction 
contributes to the initiation and development of athe-
rosclerosis and cardiovascular disease. We examined 
the association between mitochondrial DNA (mtDNA) 
copy number and microalbuminuria in a cross-sec-
tional community-based study. We measured periph-
eral blood mtDNA copy number in 694 adults without 
chronic kidney disease by a real-time PCR method. The 
overall prevalence of microalbuminuria (defined as an 
albumin creatinine ratio of 30 to 299 mg/g) was 4.5%. 
The prevalence of microalbuminuria decreased pro-
gressively from the lower to the upper quartiles of 
mtDNA copy number (6.9%, 5.7%, 2.9%, and 2.3% in 
quartiles 1, 2, 3, and 4, respectively, P = 0.017 for trend). 
Multiple logistic regression models showed that the 
quartile of mtDNA copy number was independently as-
sociated with the prevalence of microalbuminuria (P =
0.01 for trend). Compared with the lowest quartile, the 
highest quartile had an odds ratio of 0.22 for micro-
albuminuria (95% confidence interval, 0.05 to 0.87; P =
0.03). Higher mtDNA copy number was associated 
with the lower prevalence of microalbuminuria in a 
community-based population. 
Keywords: albuminuria; cardiovascular diseases; 
DNA, mitochondrial; mitochondria; oxidative phos-
phorylation
Introduction
The mitochondrion is the major cellular site of 
energy production and respiration involving the 
process of oxidative phosphorylation. Mitochondrial 
defects have been implicated in the pathogenesis of 
insulin resistance and type 2 diabetes (Lee et al., 
1998; Song et al., 2001; Petersen et al., 2003,  
2004; Lowell and Shulman, 2005). Several lines of 
evidence suggest that mitochondrial dysfunction 
contributes to the initiation and development of 
atherosclerosis and cardiovascular disease (Corral- 
Debrinski et al., 1992; Ballinger et al., 2002; Knight- 
Lozano et al., 2002; Madamanchi and Runge, 2007; 
Nisoli et al., 2007). Mitochondrial DNA (mtDNA) is a 
16.5 kb, double-stranded, closed circular molecule 
encoding 37 genes: 22 tRNAs, 2 rRNAs and 13 
proteins, which is vital for maintaining normal mito-
chondrial function. Decreased mitochondrial activity 
might be caused, at least partly, by reduced content 
of mtDNA. Expression of nuclear-encoded genes 
involved in oxidative phosphorylation is down- 
regulated in insulin-resistant skeletal muscle (Mootha 
et al., 2003). In addition, mtDNA copy number 
decreases by up to 50% in skeletal muscle of 
subjects with type 2 diabetes and is low in 
peripheral blood of offspring of those with type 2 
diabetes when compared with matched controls 
without a family history (Antonetti et al., 1995). 
Thus, some investigators have speculated that 
mtDNA copy number might be a surrogate marker 
of mitochondrial function (Cho et al., 2007). Indeed, 
mtDNA copy number is closely associated with 
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Variables 
Quartile of mitochondrial DNA copy number
P
I (≤ 310) II (310-560) III (560-912) IV (＞ 912)
Age (yr)      39 ± 14      38 ± 14      37 ± 13      35 ± 13 0.042
Women (%)       53.8%       54.0%        52.9%        58.4% NS
Current smoker (%)       26.2%       27.6%        25.0%        23.3% NS
Physical activity (%)       62.2%       60.3%        56.1%        62.2% NS
SBP (mmHg)    121 ± 20    120 ± 18    120 ± 16    120 ± 16 NS
BMI (kg/m2)   25.5 ± 4.8   24.9 ± 4.9   25.0 ± 4.0   25.3 ± 4.4 NS
Waist circumference (cm)   84.0 ± 12.7   81.7 ± 12.2   82.5 ± 10.7   82.2 ± 11.0 NS
Glucose (mg/dl)      98 ± 32      96 ± 15      96 ± 15      94 ± 13 NS
HOMA-IR score 1.73 (1.33-2.37) 1.66 (1.15-2.27) 1.80 (1.16-2.41) 1.95 (1.46-2.72) 0.037*
LDL-C (mg/dl)      98 ± 29      99 ± 36      98 ± 28      96 ± 30 NS
HDL-C (mg/dl)      56 ± 13      58 ± 13      56 ± 13      58 ± 13 NS
Triglyceride (mg/dl)      73 ± 40      72 ± 48      72 ± 44      67 ± 43 NS
Uric acid (mg/dl)     4.3 ± 1.0     4.4 ± 1.0     4.4 ± 0.9     4.3 ± 1.0 NS
CRP (mg/dl) 0.13 (0.06-0.34) 0.12 (0.06-0.29) 0.11 (0.06-0.22) 0.10 (0.06-0.24) 0.20
GFR (ml/min/1.73 m2)      94 ± 19      93 ± 18      90 ± 18      92 ± 18 NS
Data were expressed as Mean±SD or Median (Interquartile range). SBP indicates systolic blood pressure; BMI, body mass index; HOMA-IR, Homeostasis 
Model Assessment for insulin resistance; LDL-C, low density lipoproteins cholesterol; HDL-C, high density lipoproteins cholesterol; CRP, C-reactive protein; 
ACR, albumin creatinine ratio; GFR, glomerular filtration rate; mtDNA, mitochondrial DNA; NS, not significant. *Difference was statistical significant between 
quartile II and IV.
Table 1. Baseline characteristics of the study population by quartiles of mitochondrial DNA copy number. 
Figure 1. Distribution of mitochondrial DNA copy number by albuminuria 
status (P = 0.037).
Figure 2. The prevalence of microalbuminuria according to the quartiles 
of mitochondrial DNA copy number (P = 0.012 for trend).
several cardiovascular risk factors including insulin 
resistance, aging, and abdominal obesity (Lee et al., 
1998; Cho et al., 2007). However, few clinical 
studies have focused on the association between 
target organ damage and mtDNA copy number. 
    Microalbuminuria is associated with an increased 
risk of cardiovascular morbidity in patients with dia-
betes and hypertension, and in the general popu-
lation. The amount of urinary albumin excretion is 
considered to reflect generalized endothelial dys-
function associated with a variety of risk factors (de 
Zeeuw, 2004).
    Therefore, we investigated the relationship bet-
ween urinary albumin excretion and mtDNA copy 
number in the community-based, cross-sectional 
study. 
Results 
Mean age of study population was 37.4 ± 13.7 
years and 54.8% were women. The prevalence of 
hypertension was 12.3%, diabetes was 2.9%, and 
microalbuminuria was 4.5%. Table 1 presents ba-
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Mitochondrial DNA Odds ratio (95% CI) Pcopy number
Quartile 2*   0.73 (0.28-1.91) NS
Quartile 3*   0.38 (0.12-1.19) 0.09
Quartile 4*   0.26 (0.05-0.83) 0.03
per 10 copy increment 0.988 (0.977-0.999) 0.03
*Compared with quartile 1. These models were adjusted for sex, age, 
smoking status, physical activity, SBP, DBP, BMI, waist circumference, 
HOMA-IR score, WBC count, LDL-cholesterol, HDL-cholesterol, trigly-
ceride, uric acid, CRP, and GFR. NS indicates not significant.
Table 2. Risk for microalbuminuria of mitochondrial DNA copy 
number: multiple logistic regression analyses.
seline characteristics of the study population by 
quartile of mitochondrial DNA copy number. Sub-
jects in the upper mtDNA quartiles were younger 
than those in the lower quartiles. SBP, fasting glu-
cose, and BMI did not show any significant diffe-
rences between the quartile groups divided by the 
number of the mtDNA copy. In addition, HOMA-IR 
scores did not show any consistent changes 
across the quatile groups, while the scores were 
different from each group tested by Kruskal-Wallis 
test.
    We compared the median mtDNA copy number 
according to microalbuminuria status. Thirty-one 
subjects with microalbuminuria had a median 
mtDNA copy number of 467 (228-658), which was 
lower than median mtDNA copy number in sub-
jects with normoalbuminuria [565 (312-928), P = 
0.037] (Figure 1).
    Figure 2 presents the prevalence of micro-
albuminuria according to the quartiles of mtDNA 
copy number. The prevalence of microalbuminuria 
decreased progressively from the lower to the 
upper quartiles of mtDNA copy number (6.9%, 
5.7%, 2.9%, and 2.3% in quartiles 1, 2, 3, and 4, 
respectively, P = 0.017 for trend). 
    Finally, the independent relationship between 
mtDNA copy number and microalbuminuria was 
evaluated by multiple logistic regression analyses, 
which adjusted for sex, age, smoking status, 
physical activity, SBP, DBP, BMI, waist circumfe-
rence, HOMA-IR score, WBC counts, LDL choles-
terol, HDL cholesterol, triglyceride, uric acid, CRP, 
and GFR (Table 2). The quartiles of mtDNA copy 
number were independently associated with the 
prevalence of microalbuminuria (P = 0.011 for trend). 
Compared with the lowest quartile, the highest 
quartile had an odds ratio (OR) of 0.21 for micro-
albuminuria [95% (confidence interval) CI, 0.05 to 
0.83; P = 0.026]. Each 10-copy increments in mtDNA 
was associated with an OR of 0.988 for microal-
buminuria (95% CI, 0.977 to 0.999; P = 0.027). 
Discussion
We found a negative association between mtDNA 
copy number in peripheral blood and the preva-
lence of microalbuminuria in a community based 
population. Individuals in the higher quartile of 
mtDNA copy number had a lower prevalence of 
microalbuminuria. Previous studies have reported 
a correlation between mtDNA copy number and 
several cardiovascular risk factors such as aging 
and insulin resistance (Lee et al., 1998; Song et 
al., 2001). Our population-based study demons-
trated that after adjusting for various cardiovas-
cular risk factors, mtDNA copy number had an 
independent, negative association with microalbu-
minuria. Microalbuminuria reflects vascular damage 
and appears to be a surrogate marker of early 
atherosclerosis in patients with or without diabetes 
and/or hypertension (de Zeeuw, 2004). This ne-
gative association between mtDNA copy number 
and microalbuminuria suggests that low mtDNA 
content may be involved in the pathogenesis of 
endothelial dysfunction. It has become increasingly 
evident that decreased mitochondrial oxidative 
phosphorylation contributes to the initiation and 
development of atherosclerosis. Atherosclerotic 
patients show greater mtDNA damage in both the 
heart and the aorta than do healthy controls 
(Corral-Debrinski et al., 1992; Ballinger et al., 2002). 
Cardiovascular disease risk factors such as toba-
cco smoke exposure and hypercholesterolemia are 
associated with increased mtDNA damage (Knight- 
Lozano et al., 2002).
    Reactive oxygen species (ROS) may be one 
pathway linking mitochondrial dysfunction with athe-
rosclerosis, because mitochondrial respiratory chain 
is a major source of ROS as byproducts of normal 
cell respiration. Mitochondrial dysfunction may im-
pair respiratory chain function and thereby increase 
the electron leak in the electron transport chain 
and ROS production (Puddu et al., 2005). mtDNA 
is also vulnerable to damage by ROS, because it is 
not protected by histone proteins and is located 
closed to the inner mitochondrial membrane, 
where ROS are generated (Croteau et al., 1999). 
Increased production of ROS in mitochondria 
damages mtDNA and decreases the steady-state 
level of mtDNA-encoded mRNA transcripts and 
mitochondrial protein synthesis in vascular smooth 
muscle cells (Ballinger et al., 2000). This may ge-
nerate a vicious cycle leading to progressive accu-
mulation of mtDNA damage and ROS production, 
and, consequently, atherosclerosis (Heinecke, 1998). 
    It has not been demonstrated whether reduced 
mtDNA copy number in peripheral blood reflects 
decreased capacity for oxidative phosphorylation. 
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However, mtDNA copy number in peripheral blood 
correlates with insulin resistance in the offspring of 
type 2 diabetic patients (Song et al., 2001; Cho et 
al., 2007). Impaired mitochondrial function measu-
red directly by nuclear magnetic resonance is 
associated with insulin resistance in the elderly 
(Petersen et al., 2003). The rates of mitochondrial 
phosphorylation in skeletal muscle is lower in 
insulin-resistant individuals than in healthy control 
(Petersen et al., 2004). Moreover, expression of 
nuclear-encoded genes involved in oxidative phos-
phorylation is down-regulated in insulin-resistant 
skeletal muscle (Mootha et al., 2003). From these 
similar observations, we speculate that mtDNA 
copy number in peripheral blood cells is a surro-
gate marker of whole body mitochondrial function.
    Mitochondrial dysfunction and overproduction of 
ROS have emerged as a potential mechanism of 
renal complication in diabetes and hypertension 
(Nishikawa et al., 2000a, b; de Cavanagh et al., 
2006). Proteinuria and mitochondrial ROS produc-
tion simultaneously higher in the hypertensive rat 
than in normotensive rats (de Cavanagh et al., 
2006). In addition, gene delivery to reduce mito-
chondrial ROS production attenuates proteinuria 
and renal hypertrophy in diabetic mice (Zhang et 
al., 2006). It is still unclear whether mitochondrial 
ROS production is a common pathway to induce 
proteinuria and renal progression. Conversely, 
albumin exposure activates mitochondrial apoptotic 
pathways and increases ROS production in 
proximal tubule cells (Erkan et al., 2007).
    Our study has some limitations. Because it was 
a cross-sectional study, we could not examine the 
effect of reduced mtDNA content over time. Only 
one morning urine sample was obtained to mea-
sure ACR. This is commonly done in epidemio-
logic studies, but in the clinical setting, it is 
recommended that several samples should be 
obtained for each subject because of microalbu-
minuria variability and false-positive results (Molitch 
et al., 2003). Our sample was exclusively Asian, 
which may limit generalizations from our findings. 
Our population had several unique characteristics; 
such as its geographic isolation and social struc-
ture comprising large extended families, which 
maintain a nomadic lifestyle and have little access 
to health services. Our population was much 
younger and had a lower prevalence of hyper-
tension, diabetes, dyslipidaemia, and obesity than 
other population-based studies. These characteris-
tics can explain the low prevalence of microalbu-
minuria in our study. 
    In conclusion, higher mtDNA copy number was 
independently associated with lower prevalence of 
microalbuminuria in our community-based study. 
This suggests that reduced mtDNA content in 
peripheral blood may be involved in the pathoge-
nesis of endothelial dysfunction. Further study is 
needed to clarify whether mtDNA content of 
peripheral blood is associated with mitochondrial 
function in the steady state. 
Methods
Study population
Existing DNA samples and data from the GENe DIScovery 
for Complex traits in Asian population of Northeast (GEN-
DISCAN) project were used in this study. The GEN-
DISCAN project was designed originally to investigate 
genetic susceptibility to disease with complex trait disease 
and was conducted in Dashbalbar, Dornot Province, Mon-
golia, from 2005 to 2006 (Gombojav et al., 2008). Inves-
tigators requested that all inhabitants older than 10 years 
participate in this cross-sectional survey; 2327 subjects 
(about 58% all inhabitants older than 10 years) responded 
to the investigators’ request, from which the investigators 
of the GENDISCAN project selected 1002 individuals as 
predefined criteria. The participants underwent a medical 
interview and physical examination and provided a fasting 
blood sampling for DNA analysis and other laboratory 
tests, and a random urine sample. The institutional review 
board (IRB) of Ministry of Health and Welfare in Mongolia 
and the IRB of Seoul National University in Korea 
approved the GENDISCAN project, and all participants 
gave written informed consents.
    For this study, we excluded 283 children (younger than 
18 years) and 25 patients with chronic kidney disease 
(CKD), which left 694 subjects for the primary analysis. 
Assessment of clinical parameters
Data about physical activity and smoking were recorded. 
Smoking status was categorized as smoker (meaning a 
person who currently smoked or one who had smoked 
within one year) and non-smoker. A physically active 
person was defined as someone who exercised or 
performed physical work for more than 30 min three times 
a week. Blood pressure was measured in the sitting po-
sition after a five-minute rest. And the averages of three 
measurements were recorded. Hypertension was defined 
as systolic blood pressure (SBP) of at least 140 mmHg or 
diastolic blood pressure (DBP) of at least 90 mmHg. Body 
mass index (BMI) was computed as weight in kilograms 
divided by the square of height in meters. The waist 
circumference at the umbilicus was measured while the 
subject stood and was rounded to the nearest centimeter. 
An eight hour fasting blood sample was taken to determine 
the concentrations of triglyceride, LDL cholesterol, HDL 
cholesterol, glucose, uric acid, insulin, and C-reactive 
protein (CRP). Diabetes was defined as a fasting blood 
glucose level of 126 mg/dl or more. Homeostasis Model 
Assessment for insulin resistance (HOMA-IR) score was 
calculated by the following formula: [fasting serum insulin 
(μU/ml) × fasting plasma glucose (mg/dl)] / 405. Glome-
rular filtration rate (GFR) was estimated by the abbreviated 
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MDRD Study Equation (Levey et al., 1999). A random 
urine sample was obtained to determine the albumin to 
creatinine ratio (ACR). Urinary albumin concentration was 
measured by an immunoturbidimetric assay and urinary 
creatinine concentration was measured by the Jaffe rate 
reaction. Microalbuminuria was defined as an ACR of 30 to 
299 mg/g for both men and women. Subjects with an ACR 
of ＜ 30 mg/g were defined as having normoalbuminuria. 
CKD was defined as a reduced estimated GFR (＜ 60 
ml/min/ 1.73 m2) or macroalbuminuria (ACR ≥ 300 mg/g). 
Patients with CKD were excluded from the study.
Quantitation of mtDNA copy number
We purified the total cellular DNA from peripheral leuko-
cytes, and measured the mtDNA copy number and nuclear 
DNA copy number using the real time PCR method with an 
ABI Prism 7900HT (Applied Biosystems) as described pre-
viously (Song et al., 2001). The mtDNA copy number was 
corrected by 28S rRNA contents. We used the specific 
fluorescent probes for mtDNA and 28S rRNA. They were 
labeled internally using the fluorescent dyes 5-carboxy-
fluorescein (FAM) on the 5' end, and 6-carboxy-tetramethyl- 
rhodamine (TAMRA) on the 3' end. We used the primers 
for mtDNA, mt2981 (5'ACGACCTCGATGTTGAGATC3') 
and mt3245 (5'GCTCTGCCATCTTAACAAACC3'), with the 
mtDNA probe together (5'FAM-TTCAGACCGGAGTA-
ATCCAGGTCG-TAMRA3' made to nt 3071-3095). The 
primers of 28S rRNA were 28S-7358 (5'TTAAGGTAGCC-
AAAAATGCCTCG3') and 28S-7460 (5'CCTTGGCTGTG-
GTTTCGCT3'). The 28S rRNA probe was 5'-FAM-TG-
AACGAGATTCCCACTGTCCCCCTACCTACTAAATC- 
TAMRA3' made to nt7408-7440. 
    We added DNA to the PCR mixture which contained the 
primers (10 pmol each), 200 nM Taqman probe, Premix Ex 
Taq 200 nM (Takara bio Inc) and performed the PCR 
amplification for mtDNA and the reference 28S rRNA 
separately. We measured the amount of target by a 
standard curve of Ct values from known concentrations of 
the standard plasmid DNA with mtDNA and 28S rRNA, 
respectively. The following conditions was used for ampli-
fication; one cycle of 50oC for 2 min, one cycle of 95oC for 
10 min, and 40 cycles of 95oC for 15 s and 60oC for 1 min. 
Statistical analysis
Baseline characteristics were assessed according to 
quartile of mtDNA copy number. Difference between the 
quartile groups were tested for statistical significance by χ2 
test for categorical variables and one way ANOVA for 
continuous variables except for CRP levels and HOMA-IR 
score. CRP levels and HOMA-IR score were compared 
using the Kruskal-Wallis test. mtDNA copy number was 
compared between normoalbuminuria group and micro-
albuminuria group using the Mann-Whitney test. To assess 
the independent effect of mtDNA copy number on micro-
albuminuria, we used multiple logistic regression analyses 
adjusted for sex, age, smoking status, physical activity, 
SBP, DBP, BMI, waist circumference, HOMA-IR score, 
white blood cell (WBC) counts, LDL cholesterol, HDL 
cholesterol, triglyceride, uric acid, CRP, and GFR. CRP 
levels were highly skewed and were normalized by 
logarithmic transformation in regression analyses. A 
P-value of less than 0.05 was considered significant. All 
the statistical analyses for this study were conducted with 
SPSS 13.0 for Windows.
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